2017 MULTIMEDIA

- Archives -

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

UMass Medical School depression expert Anthony Rothschild, MD, is conducting a clinical trial of ketamine for patients with treatment-resistant depression.

Trailblazing women of UMass Medical School honored at Women’s History Month celebration

Trailblazing women of UMass Medical School honored at Women’s History Month celebration

Marianne Felice, MD, delivered the keynote speech at the Women’s History Month celebration that honored trailblazing women at UMass Medical School.

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Javier Elbio Irazoqui, PhD, associate professor of microbiology & physiological systems, is interested in fundamental mechanisms of innate immunity and inflammation.

UMass Medical School celebrates largest match ever with 127 residencies for the Class of 2017

UMass Medical School celebrates largest match ever with 127 residencies for the Class of 2017

UMass Medical School celebrated its largest match on Friday, March 17, when the School of Medicine Class of 2017 opened their envelopes in unison at noon sharp.

Expert’s Corner: Mark Johnson studies a treatable brain disorder that often goes undiagnosed

Expert’s Corner: Mark Johnson studies a treatable brain disorder that often goes undiagnosed

Mark D. Johnson, MD, PhD, chair and professor of neurosurgery, studies normal pressure hydrocephalus (NPH), and is focused on developing a simple, readily accessible test to identify patients who have it. 

Neil Aronin studies gene silencing to treat Huntington’s disease

Neil Aronin studies gene silencing to treat Huntington’s disease

In this Expert's Corner video, Neil Aronin, MD, professor of medicine, co-director of the Neurotherapeutics Institute and a globally recognized leader in the field, talks about exploring a promising new therapeutic approach to Huntington's disease based on gene silencing or RNA interference.

Zhiping Weng works to accelerate understanding of genome regulation with ENCODE 4 project

Zhiping Weng works to accelerate understanding of genome regulation with ENCODE 4 project

Zhiping Weng, PhD, director of the Bioinformatics and Integrative Biology Program, has received $7.2 million from the NIH to continue an international effort to catalog all the genes and regulatory elements in the human genome. She talks about her research in this Women in Science video.

Jill Zitzewitz is unraveling protein misfolding to understand disease

Jill Zitzewitz is unraveling protein misfolding to understand disease

Jill A. Zitzewitz, PhD, associate professor of biochemistry & molecular pharmacology, is working to decipher the molecular basis of protein misfolding diseases, such as ALS and Alzheimer’s. Hear more about her research and mentoring in this Women in Science video.

Shlomit Schaal develops methods for early detection of diabetic retinopathy

Shlomit Schaal develops methods for early detection of diabetic retinopathy

Shlomit Schaal, MD, PhD, professor and chair ophthalmology, featured in the latest Women in Science video, studies diabetic retinopathy disease. 

U.S. Rep. James McGovern, local health care leaders discuss impact of Affordable Care Act repeal

U.S. Rep. James McGovern, local health care leaders discuss impact of Affordable Care Act repeal

Speaking to a packed room of local health care leaders at UMass Medical School on Wednesday, Jan. 18, U.S. Rep. James McGovern (D-MA 2nd District) encouraged the crowd to join the Massachusetts congressional delegation in pressing Congress to maintain the Affordable Care Act. 

Showing 1-10 of 11 items
of 2

Stay Connected with UMassMedNow

For the Media
▴ Back To Top
Section Menu To Top